
Pascalis Vergidis MD, MSc
@pascalisid
Associate Professor @MayoClinicINFD | HemOnc ID Chair @MayoTransplant | Microbiology @MayoClinicSOM | Member-At-Large @MSG_ERC | Editor @JournalSpectrum
ID: 1122216245477224451
https://www.mayoclinic.org/biographies/vergidis-paschalis-m-d/bio-20460355 27-04-2019 19:09:37
516 Tweet
1,1K Followers
1,1K Following

#MayoIDFellowship Grand Rounds Novel antifungal drugs and diagnostics presented by Dr. Pascalis Vergidis MD, MSc Vergidis



ID Grand Rounds Mayo Clinic Infectious Diseases I discussed the following: - ONE Health - Aspergillus urine antigen - Giant magnetoresistance-enabled PCR - Rezafungin for prevention in bone marrow transplant - Ibrexafungerp (FURI) - Olorofim (Study 32) - Our experience with fosmanogepix


My recent work on display ESCMID ESCMID Fungal Infection Study Group (EFISG) looked at rising fluconazole resistance in C. parapsilosis. Our reference lab Mayo Clinic Infectious Diseases has seen a (concerning!) rise in fluconazole resistance from ~5-10% to 20% in the past 3 years. Thanks Pascalis Vergidis MD, MSc for mentorship.



New manuscript in Journal of Infectious Diseases - we report a concerning rise in fluconazole resistance in Candida parapsilosis bloodstream isolates at our (referral) lab over the past several years. Consider susceptibility testing prior to transitioning to fluconazole. academic.oup.com/jid/advance-ar…

Congrats Jack🎉 Important study Mayo Clinic Infectious Diseases Pascalis Vergidis MD, MSc S. Mac Chesdachai MSGERC



In a phase 3 clinical trial, pemivibart provided prophylactic efficacy against COVID-19 in immunocompromised patients and individuals at risk for exposure. Four of 623 participants experienced anaphylactic reactions Clinical Infectious Diseases transplantid.net academic.oup.com/cid/advance-ar…

High Kaposi sarcoma-associated herpesvirus seroprevalence in donors and recipients with HIV, particularly among MSM. Reassuringly, disease was rare Clinical Infectious Diseases transplantid.net academic.oup.com/cid/advance-ar…


Synthesis of the available literature on the use of CMV-specific T-cell therapy in adult and pediatric HSCT and SOT recipients. Several patients on concurrent antivirals, which confounded the effectiveness of VSTs Clinical Infectious Diseases transplantid.net academic.oup.com/cid/advance-ar…

Visited the historic city of Philadelphia to attend the American Board of Internal Medicine (ABIM) New Governance Orientation. Looking forward to serving on the Infectious Disease Approval Committee. Of the profession, for the public American Board of Internal Medicine (ABIM)




【Blastemia portrays a poor prognosis in acute leukemia patients with invasive pulmonary aspergillosis】 Excited to share our recent article on the “B-index” in invasive pulmonary aspergillosis! MD Anderson Cancer Center In addition to the D-index, blastemia is an important prognostic



Thursday AM conference at Mayo Clinic Infectious Diseases where our excellent senior fellows Melissa Kerkelis and Jack McHugh present 6 rapid review cases. At our fellowship, Thursday AM conference presents one of the many opportunities for fellows/residents to teach the division. 📖 👓
